In silico modeling to optimize interpretation of liver safety biomarkers in clinical trials.
about
In silico modeling to optimize interpretation of liver safety biomarkers in clinical trials.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
In silico modeling to optimize ...... biomarkers in clinical trials.
@en
In silico modeling to optimize ...... biomarkers in clinical trials.
@nl
type
label
In silico modeling to optimize ...... biomarkers in clinical trials.
@en
In silico modeling to optimize ...... biomarkers in clinical trials.
@nl
prefLabel
In silico modeling to optimize ...... biomarkers in clinical trials.
@en
In silico modeling to optimize ...... biomarkers in clinical trials.
@nl
P2860
P356
P1476
In silico modeling to optimize ...... biomarkers in clinical trials
@en
P2093
Paul B Watkins
Rachel J Church
P2860
P304
P356
10.1177/1535370217740853
P577
2017-11-02T00:00:00Z